General practitioners’ decisions about discontinuation of medication: an explorative study

Journal of Health Organization and Management

Volumn 30, Issue 4, 2016, Pages 565-580

  Nixon, Michael Simon ^a   Vendelø, Morten Thanning ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Copenhagen Business School ^*  (Denmark)

Author keywords

Decision making; Deprescribing; Discontinuation; General practitioners; Institutional context; Medication

Indexed keywords

CONCEPTUAL FRAMEWORK; CONSENSUS DEVELOPMENT; DECISION MAKING; DRAWING; EMBEDDING; GENERAL PRACTITIONER; HUMAN; PRESCRIPTION; BEHAVIORAL OBSERVATION; INTERVIEW; PSYCHOLOGY; QUALITATIVE RESEARCH; TREATMENT WITHDRAWAL;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BEHAVIOR OBSERVATION TECHNIQUES; DECISION MAKING; GENERAL PRACTITIONERS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERVIEWS AS TOPIC; QUALITATIVE RESEARCH; WITHHOLDING TREATMENT;

EID: 84975032523     PISSN: 14777266     EISSN: None     Source Type: Journal    
DOI: 10.1108/JHOM-01-2015-0011     Document Type: Article

References (41)

1. Anderson, K., Stowasser, D., Freeman, C. and Scott, I. (2014), “Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis”, BMJ Open, Vol. 2014 No. 4, p. e006544.
2. Bain, K.T., Holmes, H.M., Beers, M.H., Maio, V., Handler, S.M. and Pauker, S.G. (2008), “Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process”, Journal of the American Geriatrics Society, Vol. 56 No. 10, pp. 1946-1952.
3. Best Practice Advocacy Centre New Zealand (2010), “A practical guide to stopping medicines in older people”, Best Practice Journal, Vol. 27, pp. 10-23.
4. Campo, K., De Staebel, O., Gijsbrecht, E. and Waterschoot, W. (2005), “Physicians’ decision process for drug prescription and the impact of pharmaceutical marketing mix instruments”, Health Marketing Quarterly, Vol. 22 No. 4, pp. 73-107.
5. Cassel, C. and Guest, J. (2012), “Choosing wisely: helping physicians and patients make smart decisions about their care”, Journal of the American Medical Association, Vol. 307 No. 17, pp. 1801-1802.
6. Christensen, B. (2007), Klinisk vejledning: forebyggelse af iskæmisk hjerte-kar-sygdom i almen praksis (Clinical guidelines: prevention ischaemic heart disease in general practice), 3rd ed., Dansk Selskab for Almen Medicin (Danish College of General Practice), København.
7. Clinch, M. and Benson, J. (2013), “Making information ‘relevant’: general practitioner judgments and the production of patient involvement”, Social Science & Medicine, Vol. 96, pp. 104-111.
8. Dahlgren, L., Emmelin, M. and Winkvist, A. (2007), Qualitative Methodology for International Public Health, Umeå University, Umeå.
9. Dunn, M.B. and Jones, C. (2010), “Institutional logics and institutional pluralism: the contestation of of care and science logics in medical education, 1967-2005”, Administrative Science Quarterly, Vol. 55 No. 1, pp. 114-149.
10. Fuller, R. (2004), “Managing health risks: junior doctors’ view of risk and decision making”, Journal of Health Organization and Management, Vol. 18 No. 3, pp. 155-178.
11. Garfinkel, D. and Mangin, D. (2010), “Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy”, Archives of Internal Medicine, Vol. 170 No. 18, pp. 1648-1654.
12. Gioia, D., Corley, K. and Hamilton, A. (2012), “Seeking qualitative rigor in inductive research: notes on the Gioia methodology”, Organizational Research Methods, Vol. 16 No. 1, pp. 15-31.
13. Gnjidic, D., Le Couteur, D.G., Kouladjian, L. and Hilmer, S.N. (2012), “Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes”, Clinics in Geriatric Medicine, Vol. 28 No. 2, pp. 237-253.
14. Grady, D. and Redberg, R. (2010), “Less is more: how less health care can result in better health”, Archives of Internal Medicine, Vol. 170 No. 9, pp. 749-750.
15. Graves, T., Hanlon, J.T., Schmader, K.E., Samsa, G.P., Pieper, C.F. and Weinberger, M. (1997), “Adverse events after discontinuing medications in elderly outpatients”, Archives of Internal Medicine, Vol. 157 No. 19, pp. 2205-2210.
16. Greenhalgh, T., Howick, J. and Maskrey, N. (2014), “Evidence based medicine: a movement in crisis?”, British Medical Journal, Vol. 2014 No. 348, p. 3725.
17. Heebøll-Nielsen, N., Holme, P., Mcnair, A. and Nielsen, E. (2011), “Kolesterol – hvornår er forebyggende behandling med statin indiceret? (Cholesterol – when is preventive treatment with statins indicated?)”, Rationel Farmakoterapi, Vol. 2011 No. 4, pp. 1-4.
18. Iyer, S., Naganathan, V., McLachlan, A.J. and Le Couteur, D.G. (2008), “Medication withdrawal trials in people aged 65 years and older: a systematic review”, Drugs & Aging, Vol. 25 No. 12, pp. 1021-1031.
19. Jensen, T.B., Kjærgaard, A. and Svejvig, P. (2009), “Using institutional theory with sensemaking theory: a case study of information system implementation in healthcare”, Journal of Information Technology, Vol. 24 No. 4, pp. 343-353.
20. Mangin, D., Heath, I. and Jamoulle, M. (2012), “Beyond diagnosis: rising to the multimorbidity challenge”, British Medical Journal, Vol. 2012 No. 344, p. 3526.
21. Mcdonnell, T. and Group, N. (2008), “Antibiotic overuse: the influence of social norms”, Journal of the American College of Surgeons, Vol. 207 No. 2, pp. 265-275.
22. Meyer, J.W. (1994), “Institutional and organizational rationalization in the mental health system”, in Scott, W.R. and Meyer, J.W. (Eds), Institutional Contexts and Organizations – Structural Complexity and Individualism, Sage, Thousand Oaks, CA, pp. 215-227.
23. Ostini, R., Jackson, C., Hegney, D. and Tett, S. (2011), “How is medication prescribing ceased? A systematic review”, Medical Care, Vol. 49 No. 1, pp. 24-36.
24. Ray, K.K., Seshasai, S.R.K., Erqou, S., Sever, P., Jukema, J.W., Ford, I. and Sattar, N. (2010), “Statins and all-cause mortality in high-risk primary prevention”, Archives of Internal Medicine, Vol. 170 No. 12, pp. 1024-1031.
25. Reeve, E., Shakib, S., Hendrix, I., Roberts, M.S. and Wiese, M.D. (2014), “The benefits and harms of deprescribing”, The Medical Journal of Australia, Vol. 201 No. 7, pp. 386-389.
26. Reeve, E., Wiese, M.D., Hendrix, I., Roberts, M.S. and Shakib, S. (2013), “People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe”, Journal of the American Geriatrics Society, Vol. 61 No. 9, pp. 1508-1514.
27. Schuling, J., Gebben, H., Veehof, L.J.G. and Haaijer-Ruskamp, F.M. (2012), “Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study”, BMC Family Practice, Vol. 56 No. 13, pp. 1-7.
28. Scott, W.R. (2003), Organizations – Rational, Natural and Open Systems, 5th ed., Prentice-Hall, Upper Saddle River, NJ.
29. Scott, W.R. (2007), Institutions and Organizations: Ideas, Interests and Identities, 3rd ed., Sage, Thousand Oaks, CA.
30. Scott, I., Gray, L., Martin, J., Pillans, P. and Mitchell, C. (2012), “Deciding when to stop: towards evidence-based deprescribing of drugs in older populations”, Evidence Based Medicine, Vol. 18 No. 4, pp. 121-124.
31. Straand, J. and Sandvik, H. (2001), “Stopping long-term drug therapy in general practice. How well do physicians and patients agree?”, Family Practice, Vol. 18 No. 6, pp. 597-601.
32. Strandberg, T.E., Kolehmainen, L. and Vuorio, A. (2014), “Evaluation and treatment of older patients with hypercholesterolemia”, Journal of the American Medical Association, Vol. 312 No. 11, pp. 1136-1144.
33. Taylor, F., Huffman, M.D., Macedo, A.F., Moore, T.H., Burke, M., Davey Smith, G., Ward, K. and Ebrahim, S. (2011), “Statins for the primary prevention of cardiovascular disease”, Cochrane Database of Systematic Reviews, Vol. 2011 No. 1, p. CD004816.
34. The NHS Information Centre, Prescribing Support Unit (2010), Prescriptions Dispensed in the Community: England, Statistics for 1999 to 2009, The Health and Social Care Information Centre, Leeds.
35. Tracy, S.J. (2010), “Qualitative quality: eight ‘big-tent’ criteria for excellent qualitative research”, Qualitative Inquiry, Vol. 16 No. 10, pp. 837-851.
36. Turner, J.P., Shakib, S., Singhal, N., Hogan-Doran, J., Prowse, R., Johns, S. and Bell, J.S. (2014), “Statin use and pain in older people with cancer: a cross-sectional study”, Journal of the American Geriatrics Society, Vol. 62 No. 10, pp. 1900-1905.
37. Walley, T., Folino-Gallo, P., Stephens, P. and Van Ganse, E. (2005), “Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003”, British Journal of Clinical Pharmacology, Vol. 60 No. 5, pp. 543-551.
38. Weber, K. and Glynn, M.A. (2006), “Making sense with institutions: context, thought and action in Karl Weick’s theory”, Organization Studies, Vol. 27 No. 11, pp. 1639-1660.
39. Weick, K. (1995), Sensemaking in Organisations, 1st ed., Sage, Thousand Oaks, CA.
40. Weick, K., Sutcliffe, K.M. and Obstfeld, D. (2005), “Organizing and the process of sensemaking”, Organization Science, Vol. 16 No. 4, pp. 409-421.
41. World Medical Association (2001), “World medical association declaration of Helsinki. ethical principles for medical research involving human subjects”, Bulletin of the World Health, Vol. 79 No. 4, pp. 373-374.